2024

Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
Abeck F, Hansen I, Kött J, Schröder F, Garrahy E, Veneroso J, Rünger A, Torster L, Schneider S, von Büren J
J COSMET DERMATOL-US. 2024;23(9):2956-2963.

Effects of a skin type diversity seminar on undergraduate medical students' self-assessed competence in managing skin diseases in patients with skin of color
Abeck F, Heinen I, Sommer R, Blome C, Härter M, Augustin M, Schneider S, Hansen-Abeck I, Booken N
BMC MED EDUC. 2024;24(1):848.

Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients
Hansen-Abeck I, Geidel G, Abeck F, Kött J, Cankaya R, Dobos G, Mitteldorf C, Nicolay J, Albrecht J, Menzer C, Livingstone E, Mengoni M, Braun A, Wobser M, Klemke C, Tratzmiller S, Assaf C, Terheyden P, Klespe K, Schneider S, Booken N
J DTSCH DERMATOL GES. 2024 [Epub ahead of print].

Successful treatment of refractory checkpoint inhibitor-induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
Hansen I, Kött J, Heidenreich S, Ayuk F, Doll P, Abeck F, Booken N, Gebhardt C, Schneider S
Journal of the European Academy of Dermatology and Venerology Clinical Practice. 2024;3(1):317-320.

C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma
Kött J, Zimmermann N, Zell T, Heidrich I, Geidel G, Rünger A, Smit D, Merkle M, Parnian N, Hansen I, Hoehne I, Abeck F, Torster L, Weichenthal M, Pantel K, Schneider S, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(8):1575–1587.

Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy
Kött J, Zimmermann N, Zell T, Rünger A, Heidrich I, Geidel G, Smit D, Hansen I, Abeck F, Schadendorf D, Eggermont A, Puig S, Hauschild A, Gebhardt C
EUR J CANCER. 2024;202:.

2023

A Rejected Hypothesis: Phenomenon of High Treatment Adherence in Direct-to-Consumer Teledermatology Despite Lack of Direct Physician-Patient Interaction
Abeck F, Hansen I, Wiesenhütter I, Brookman-May S, Sharaf K, Kött J, Bertlich M, Schneider S, von Büren J
TELEMED E-HEALTH. 2023;29(7):1051-1056.

Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia
Abeck F, Hansen I, Wiesenhütter I, Schröder F, Kött J, Schneider S, von Büren J
CLIN COSMET INV DERM. 2023;16:937-945.

Direct-to-Consumer Teledermatology in Germany: A Retrospective Analysis of 1,999 Teleconsultations Suggests Positive Impact on Patient Care
Abeck F, Kött J, Bertlich M, Wiesenhütter I, Schröder F, Hansen I, Schneider S, von Büren J
TELEMED E-HEALTH. 2023;29(10):1484-1491.

A case of COVID-19-associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA
Abeck F, Vehring J, Varwig-Janßen D, Menz A, Christolouka M, Schneider S
J EUR ACAD DERMATOL. 2023;37(12):e1372-e1374.

Schnelle Abheilung einer schweren Psoriasis vulgaris bei einem HIV-positiven Patienten unter antiretroviraler Therapie
Bauditz L, Booken N, Schneider S, Abeck F
DERMATOLOGIE. 2023;74(4):282-285.

The potential of telemedicine for dermatological care of pediatric patients in Germany
Hansen I, Abeck D, Kött J, Schneider S, Abeck F
J DTSCH DERMATOL GES. 2023;21(2):141-145.

Asymptomatic erythematous plaque on the lower leg
Hansen I, Abeck F, Heidrich I, Schneider S, Booken N
J DTSCH DERMATOL GES. 2023;21(7):813-815.

Asymptomatische erythematöse Plaque am Unterschenkel
Hansen I, Abeck F, Heidrich I, Schneider S, Booken N
J DTSCH DERMATOL GES. 2023;21(7):813-815.

Therapie des nekrobiotischen Xanthogranuloms - Fallserie und aktuelle Literatur:
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1319.

Therapy of necrobiotic xanthogranuloma - case series and review of the literature
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1318.

Letaler Verlauf einer Kryoglobulinämie Typ I
Hansen I, Ghandili S, Abeck F, Kött J, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(Suppl 2):15-18.

Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab
Hansen I, Heidrich I, Abeck F, Kött J, Booken N, Gebhardt C, Schneider S
J EUR ACAD DERMATOL. 2023;37(5):e621-e623.

Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
von Büren J, Hansen I, Kött J, Schröder F, Veneroso J, Schneider S, Abeck F
DIGIT HEALTH. 2023;9:20552076231205740.

2022

Unsachgemäße Systemtherapie bei schwerer atopischer Dermatitis – fatale Langzeitschäden
Abeck F, Booken N, Schneider S
HAUTARZT. 2022;73(8):638-640.

Telemedical care of men with androgenetic alopecia demonstrates improved access to care and patient benefit
Abeck F, Kött J, Wiesenhütter I, Hiebenthal T, Hansen I, Schneider S, von Büren J
J EUR ACAD DERMATOL. 2022;36(12):e1018-e1020.

Adherence to Guideline-Oriented Preventive Measures in Patients with Atopic Dermatitis in Germany
Zyriax B, Augustin M, Abeck F, Mohr N, Kirsten N, Langenbruch A
DERMATOLOGY. 2022;238(2):307-312.

2021

Qualität der dermatologischen Versorgung von Neurodermitis in Deutschland – keine Verbesserung der Indikatoren nach 10 Jahren
Langenbruch A, Mohr N, Abeck F, Schmitt J, Ständer S, Werfel T, Thaci D, Weidinger S, Augustin M
HAUTARZT. 2021;72(12):1079-1089.

2020

Vesicular Skin Reactions After Stress ECG
Abeck F, Goethem S
DTSCH ARZTEBL INT. 2020;117(26):451.

2019

Die Bedeutung des Glykämischen Index und der Glykämischen Last von Kohlenhydraten bei Acne vulgaris
Abeck F, Kirsten N, Zyriax B
AKTUEL DERMATOL. 2019;45(5):209-514.

Letzte Aktualisierung aus dem FIS: 30.10.2024 - 23:35 Uhr